Shengduo Liu

2.4k citations
11 papers · 1.7k indexed · 2 hit papers · h-index 9

Shengduo Liu

10 papers receiving 1.7k citations

Hit Papers

A non-canonical cGAS–STING–PERK pathway facilitat...1632019202620212023250500750

Peers

Shengduo Liu
Comparison fields: 5 of 104
  • Condensed Matter Physics 479
  • Immunology 433
  • Biomedical Engineering 774
  • Mechanical Engineering 532
  • Cell Biology 168
Replace Masaru Takeuchi with:
Masaru Takeuchi Japan
Akihiko Ichikawa Japan
Jiyun Kim South Korea
Abigail K. Grosskopf United States
Angelo S. Mao United States
Qingzhen Yang China
Chwee Ming Lim Singapore
Satoshi Konishi Japan
Akihiro Nishiguchi Japan
Tianzhi Luo China
Shengduo Liu relative to Masaru Takeuchi Japan Masaru Takeuchi's profile →
Citations per field
00.5×
Masaru Takeuchi · 1×
Citations per year

Countries citing papers authored by Shengduo Liu

Since Specialization
Citations

This map shows the geographic impact of Shengduo Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengduo Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengduo Liu more than expected).

Fields of papers citing papers by Shengduo Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengduo Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengduo Liu. The network helps show where Shengduo Liu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shengduo Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shengduo Liu Line = papers co-authored together Shengduo Liu links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1 20250
2 20255
3
A non-canonical cGAS–STING–PERK pathway facilitates the translational program critical for senescence and organ fibrosisbreakdown →
2022163
4 202119
5 202042
6 202064
7 2019192
8
Ferromagnetic soft continuum robotsbreakdown →
2019984
9 201732
10 2017158
11 201668

About Shengduo Liu

Shengduo Liu is a scholar working on Immunology, Infectious Diseases and Biochemistry, having authored 11 papers that have together received 1.7k indexed citations. Recurring topics across this work include interferon and immune responses (8 papers), Viral Infections and Vectors (5 papers), RNA regulation and disease (3 papers), Inflammasome and immune disorders (3 papers), Hippo pathway signaling and YAP/TAZ (2 papers), RNA Research and Splicing (2 papers), Modular Robots and Swarm Intelligence (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Condensed Matter Physics (479 citations), Immunology (433 citations) and Biomedical Engineering (774 citations). Shengduo Liu has collaborated with scholars based in China and United States. Frequent co-authors include German Alberto Parada, Yoonho Kim, Xuanhe Zhao, Pinglong Xu, Xin‐Hua Feng, Jian Zou, Fansen Meng, Ruyuan Zhou, Jun Qin and Shasha Chen. Their work appears in journals such as Nature Communications, Genes & Development and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026